Kidney Cancer, Version 2.2020 Featured Updates to the NCCN Guidelines

被引：177

作者：

Motzer, Robert J. ^{[1
]}

Jonasch, Eric ^{[2
]}

Michaelson, M. Dror ^{[3
]}

Nandagopal, Lakshminarayanan ^{[4
]}

Gore, John L. ^{[5
]}

George, Saby ^{[6
]}

Alva, Ajjai ^{[7
]}

Haas, Naomi ^{[8
]}

Harrison, Michael R. ^{[9
]}

Plimack, Elizabeth R. ^{[10
]}

Sosman, Jeffrey ^{[11
]}

Agarwal, Neeraj ^{[12
]}

Bhayani, Sam ^{[13
,14
]}

Choueiri, Toni K. ^{[15
]}

Costello, Brian A. ^{[16
]}

Derweesh, Ithaar H. ^{[17
]}

Gallagher, Thomas H. ^{[5
]}

Hancock, Steven L. ^{[18
]}

Kyriakopoulos, Christos ^{[19
]}

LaGrange, Chad ^{[20
]}

Lam, Elaine T. ^{[21
]}

Lau, Clayton ^{[22
]}

Lewis, Bryan ^{[23
]}

Manley, Brandon ^{[24
]}

McCreery, Brittany ^{[5
]}

McDonald, Andrew ^{[4
]}

Mortazavi, Amir ^{[25
,26
]}

Pierorazio, Phillip M. ^{[27
]}

Ponsky, Lee ^{[28
,29
]}

Redman, Bruce G. ^{[7
]}

Somer, Bradley ^{[30
]}

Wile, Geoffrey ^{[31
]}

Dwyer, Mary A. ^{[32
]}

Hammond, Lydia J. ^{[32
]}

Zuccarino-Catania, Griselda ^{[32
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Massachusetts Gen Hosp, Canc Center

[4] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[5] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, 1124 Columbia St, Seattle, WA 98104 USA

[6] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[7] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA

[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[9] Duke Canc Inst, Durham, NC USA

[10] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[11] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[12] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[13] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO 63110 USA

[14] Washington Univ, Sch Med, St Louis, MO 14263 USA

[15] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[16] Mayo Clin, Canc Ctr, Rochester, MN USA

[17] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[18] Stanford Canc Inst, Stanford, CA USA

[19] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[20] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[21] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[22] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[23] Kidney Canc Coalit, Philadelphia, PA USA

[24] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[25] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[26] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[27] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[28] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[29] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[30] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[31] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[32] Natl Comprehens Canc Network, Plymouth Meeting, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2019年 / 17卷 / 11期

关键词：

RENAL-CELL CARCINOMA; RADIOSURGERY ONCOLOGY CONSORTIUM; MICROVASCULAR TUMOR INVASION; TNM STAGING SYSTEM; INTERFERON-ALPHA; DOSE INTERLEUKIN-2; PHASE-III; CLASSIFICATION; THERAPY; SIZE;

D O I：

10.6004/jnccn.2019.0054

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal cell carcinoma, and are intended to assist with clinical decision-making. These NCCN Guidelines Insights summarize the NCCN Kidney Cancer Panel discussions for the 2020 update to the guidelines regarding initial management and first-line systemic therapy options for patients with advanced clear cell renal cell carcinoma.

引用

页码：1279 / 1285

页数：7

共 34 条

[11] Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma [J].

Lam, JS ;

Shvarts, O ;

Said, JW ;

Pantuck, AJ ;

Seligson, DB ;

Aldridge, ME ;

Bui, MHT ;

Liu, XL ;

Horvath, S ;

Figlin, RA ;

Belldegrun, AS .

CANCER, 2005, 103 (12) :2517-2525

[12] Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma [J].

Leibovich, Bradley C. ;

Lohse, Christine M. ;

Crispen, Paul L. ;

Boorjian, Stephen A. ;

Thompson, R. Houston ;

Blute, Michael L. ;

Cheville, John C. .

JOURNAL OF UROLOGY, 2010, 183 (04) :1309-1315

[13] Renal cell cancer histological subtype distribution differs by race and sex [J].

Lipworth, Loren ;

Morgans, Alicia K. ;

Edwards, Todd L. ;

Barocas, Daniel A. ;

Chang, Sam S. ;

Herrell, S. Duke ;

Penson, David F. ;

Resnick, Matthew J. ;

Smith, Joseph A. ;

Clark, Peter E. .

BJU INTERNATIONAL, 2016, 117 (02) :260-265

[14] Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma [J].

McDermott, DF ;

Regan, MM ;

Clark, JI ;

Flaherty, LE ;

Weiss, GR ;

Logan, TF ;

Kirkwood, JM ;

Gordon, MS ;

Sosman, JA ;

Ernstoff, MS ;

Tretter, CPG ;

Urba, WJ ;

Smith, JW ;

Margolin, KA ;

Mier, JW ;

Gollob, JA ;

Dutcher, JP ;

Atkins, MB .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :133-141

[15] Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma [J].

Mejean, A. ;

Ravaud, A. ;

Thezenas, S. ;

Colas, S. ;

Beauval, J. -B. ;

Bensalah, K. ;

Geoffrois, L. ;

Thiery-Vuillemin, A. ;

Cormier, L. ;

Lang, H. ;

Guy, L. ;

Gravis, G. ;

Rolland, F. ;

Linassier, C. ;

Lechevallier, E. ;

Beisland, C. ;

Aitchison, M. ;

Oudard, S. ;

Patard, J. -J. ;

Theodore, C. ;

Chevreau, C. ;

Laguerre, B. ;

Hubert, J. ;

Gross-Goupil, M. ;

Bernhard, J. -C. ;

Albiges, L. ;

Timsit, M. -O. ;

Lebret, T. ;

Escudier, B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05) :417-427

[16] Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group [J].

Meyer, Emmanuel ;

Pasquier, David ;

Bernadou, Guillemette ;

Calais, Gilles ;

Maroun, Pierre ;

Bossi, Alberto ;

Theodore, Christine ;

Albiges, Laurence ;

Stefan, Dinu ;

de Crevoisier, Renaud ;

Hennequin, Christophe ;

Lagrange, Jean-Leon ;

Grellard, Jean-Michel ;

Clarisse, Benedicte ;

Licaj, Idlir ;

Habrand, Jean-Louis ;

Carrie, Christian ;

Joly, Florence .

EUROPEAN JOURNAL OF CANCER, 2018, 98 :38-47

[17] Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma - Long-term analysis in 213 patients [J].

Minervini, A ;

Lilas, L ;

Minervini, R ;

Selli, C .

CANCER, 2002, 94 (10) :2590-2595

[18]

Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.3.CO

[19]

2-H

[20] Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma [J].

Motzer, R. J. ;

Tannir, N. M. ;

McDermott, D. F. ;

Frontera, O. Aren ;

Melichar, B. ;

Choueiri, T. K. ;

Plimack, Elizabeth R. ;

Barthelemy, P. ;

Porta, C. ;

George, S. ;

Powles, T. ;

Donskov, F. ;

Neiman, V. ;

Kollmannsberger, C. K. ;

Salman, P. ;

Gurney, H. ;

Hawkins, R. ;

Ravaud, A. ;

Grimm, M. -O. ;

Bracarda, S. ;

Barrios, C. H. ;

Tomita, Y. ;

Castellano, D. ;

Rini, B. I. ;

Chen, A. C. ;

Mekan, S. ;

McHenry, M. B. ;

Wind-Rotolo, M. ;

Doan, J. ;

Sharma, P. ;

Hammers, H. J. ;

Escudier, B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (14) :1277-1290

← 1 2 3 4 →